Efficacy and safety of certolizumab pegol for Crohn's disease in clinical practice
Author:
Affiliation:
1. Division of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA
2. Department of Internal Medicine; Kosin University College of Medicine; Busan Korea
Funder
UCB Pharma
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13288/fullpdf
Reference31 articles.
1. Inflammatory bowel disease;Abraham;N Engl J Med,2009
2. Tumor necrosis factor inhibitors for inflammatory bowel disease;Nielsen;N Engl J Med,2013
3. FDA approves Cimzia to treat Crohn's disease;Lang;Gastroenterology,2008
4. Maintenance therapy with certolizumab pegol for Crohn's disease;Schreiber;N Engl J Med,2007
5. Certolizumab pegol for the treatment of Crohn's disease;Sandborn;N Engl J Med,2007
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Certolizumab Pegol in Crohn's Disease Management: A Multicentric Brazilian Observational Study;Journal of Coloproctology;2024-09
2. Tailoring treatment: a comprehensive review of precision medicine and biological therapies in inflammatory bowel disease;InterConf;2023-12-20
3. Dose Escalation Patterns of Advanced Therapies in Crohn’s Disease and Ulcerative Colitis: A Systematic Literature Review;Advances in Therapy;2023-03-17
4. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions;Biologics;2021-08-10
5. Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience;Crohn's & Colitis 360;2021-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3